Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
LGL leukemia: from pathogenesis to treatment.
Lamy T, Moignet A, Loughran TP Jr. Lamy T, et al. Among authors: moignet a. Blood. 2017 Mar 2;129(9):1082-1094. doi: 10.1182/blood-2016-08-692590. Epub 2017 Jan 23. Blood. 2017. PMID: 28115367 Free article. Review.
Cyclophosphamide as a first-line therapy in LGL leukemia.
Moignet A, Hasanali Z, Zambello R, Pavan L, Bareau B, Tournilhac O, Roussel M, Fest T, Awwad A, Baab K, Semenzato G, Houot R, Loughran TP Jr, Lamy T. Moignet A, et al. Leukemia. 2014 May;28(5):1134-6. doi: 10.1038/leu.2013.359. Epub 2013 Nov 27. Leukemia. 2014. PMID: 24280867 Free PMC article. No abstract available.
Severe chronic primary neutropenia in adults: report on a series of 108 patients.
Sicre de Fontbrune F, Moignet A, Beaupain B, Suarez F, Galicier L, Socié G, Varet B, Coppo P, Michel M, Pautas C, Oksenhendler E, Lengline E, Terriou L, Moreau P, Chantepie S, Casadevall N, Michot JM, Gardembas M, Michallet M, Croisille L, Audrain M, Bellanné-Chantelot C, Donadieu J, Lamy T; French Severe Chronic Neutropenia Registry. Sicre de Fontbrune F, et al. Among authors: moignet a. Blood. 2015 Oct 1;126(14):1643-50. doi: 10.1182/blood-2015-03-634493. Epub 2015 Aug 10. Blood. 2015. PMID: 26261239 Free article.
STAT3 mutation impacts biological and clinical features of T-LGL leukemia.
Teramo A, Barilà G, Calabretto G, Ercolin C, Lamy T, Moignet A, Roussel M, Pastoret C, Leoncin M, Gattazzo C, Cabrelle A, Boscaro E, Teolato S, Pagnin E, Berno T, De March E, Facco M, Piazza F, Trentin L, Semenzato G, Zambello R. Teramo A, et al. Among authors: moignet a. Oncotarget. 2017 Jun 27;8(37):61876-61889. doi: 10.18632/oncotarget.18711. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977911 Free PMC article.
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret C, Desmots F, Drillet G, Le Gallou S, Boulland ML, Thannberger A, Doncker AV, Salaun V, Damaj GL, Veyrat-Masson R, Tournilhac O, Moignet A, Pangault C, Roussel M, Fest T, Lamy T. Pastoret C, et al. Among authors: moignet a. Blood. 2021 Jun 10;137(23):3237-3250. doi: 10.1182/blood.2020006721. Blood. 2021. PMID: 33512451 Free PMC article.
Ruxolitinib for refractory large granular lymphocyte leukemia.
Moignet A, Pastoret C, Cartron G, Coppo P, Lamy T. Moignet A, et al. Am J Hematol. 2021 Oct 1;96(10):E368-E370. doi: 10.1002/ajh.26275. Epub 2021 Jun 26. Am J Hematol. 2021. PMID: 34133042 Free article. No abstract available.
Toward a Better Classification System for NK-LGL Disorders.
Drillet G, Pastoret C, Moignet A, Lamy T, Marchand T. Drillet G, et al. Among authors: moignet a. Front Oncol. 2022 Feb 1;12:821382. doi: 10.3389/fonc.2022.821382. eCollection 2022. Front Oncol. 2022. PMID: 35178350 Free PMC article. Review.
19 results